GNL2 Polyklonaler Antikörper
GNL2 Polyklonal Antikörper für WB, IHC, IF/ICC, Indirect ELISA
Wirt / Isotyp
Kaninchen / IgG
Getestete Reaktivität
human, Maus
Anwendung
WB, IHC, IF/ICC, Indirect ELISA
Konjugation
Unkonjugiert
Kat-Nr. : 10190-2-PBS
Synonyme
Geprüfte Anwendungen
Produktinformation
10190-2-PBS bindet in WB, IHC, IF/ICC, Indirect ELISA GNL2 und zeigt Reaktivität mit human, Maus
Getestete Reaktivität | human, Maus |
Wirt / Isotyp | Kaninchen / IgG |
Klonalität | Polyklonal |
Typ | Antikörper |
Immunogen | GNL2 fusion protein Ag0243 |
Vollständiger Name | guanine nucleotide binding protein-like 2 (nucleolar) |
Berechnetes Molekulargewicht | 731 aa, 84 kDa |
Beobachtetes Molekulargewicht | 100 kDa |
GenBank-Zugangsnummer | BC000107 |
Gene symbol | GNL2 |
Gene ID (NCBI) | 29889 |
Konjugation | Unkonjugiert |
Form | Liquid |
Reinigungsmethode | Antigen-Affinitätsreinigung |
Lagerungspuffer | PBS only |
Lagerungsbedingungen | Store at -80°C. 20ul Größen enthalten 0,1% BSA. |
Hintergrundinformationen
GNL2 ( G protein nucleolar 2) has a crucial role in the pathogenesis of gliomas by influencing key cellular processes, particularly enhanced protein synthesis, which ultimately contributes to the development of gliomas. In addition, GNL2 was found to affect the overall protein synthesis of ribosomal protein L11 in glioma cells. The calculated MW of GNL2 is 84 kDa, but the observed MW is around 100 kDa, which may be due to glycosylation modification.